FDA accepts IND application for EP-7041 for thrombosis prevention in patients with COVID-19 March 4, 2021 No Comments
Initiation of phase IIa study evaluating BGE-117 in elderly with unexplained anemia Feb. 26, 2021 No Comments
Enrollment completed in phase II study of SSS-06 long-acting erythropoietin-stimulating protein Feb. 25, 2021 No Comments
New phase I study evaluates AbFero's SP-420 to treat transfusional iron overload Feb. 24, 2021 No Comments
bluebird bio temporary suspends studies of LentiGlobin gene therapy for SCD Feb. 17, 2021 No Comments
Enrollment ongoing in phase III study of LNP-023 in adults with PNH with residual anemia Feb. 11, 2021 No Comments
KalVista releases phase II data on KVD-900 as oral on-demand treatment for HAE Feb. 9, 2021 No Comments
RSS